Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.6.1.1 (
adenylate cyclase
)
19,190
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The gene for
AMP nucleosidase
from Escherichia coli (amn) has been sequenced and characterized. The gene codes for a transcript of 1.7 +/- 0.2 kb, and the open reading frame corresponds to a protein of 483 amino acids (Mr = 53848). Amino acid sequences from tryptic peptides of
AMP nucleosidase
, N-terminal amino acid analysis, and the amino acid composition confirm the gene assignment and the open reading frame of amn. Primer extension studies determined the 5'-end of the amn transcript. The 5'-regulatory region contains overlapping sequences with similarity to the consensus sequences for binding cAMP receptor protein and inorganic phosphate repressor protein. Addition of exogenous cAMP to E. coli deficient in
adenylate cyclase
resulted in a 3-fold increase in
AMP nucleosidase
activity. Growth of E. coli on limiting phosphate resulted in an 8-fold increase in the production of
AMP nucleosidase
. The amn gene was expressed in
AMP nucleosidase
deficient strains of Azotobacter vinelandii and E. coli. A pUC-amn construct is described that causes approximately 20% of the total protein in E. coli to be produced as
AMP nucleosidase
. Comparison of the amino acid sequence for
AMP nucleosidase
with that for yeast AMP deaminase indicates a region in which six of eight amino acids are identical but no other overall homology. The amino acid sequence showed poor agreement with consensus sequences for adenylate binding sites even though the enzyme is known to have a catalytic site for AMP and regulatory sites for MgATP and phosphate.
...
PMID:Structure and regulation of the AMP nucleosidase gene (amn) from Escherichia coli. 269 Sep 48